|
Pharma Marketletter
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 675 articles |
 Page 1 of 9 
|
Data support bipolar depression indication for AstraZeneca's Seroquel.
October 31, 2005
Roche expands Tamiflu production capacity.
October 31, 2005
Good results from Amgen fail to please.
October 31, 2005
Shire sues over Adderall patent.(Shire Pharmaceuticals Group PLC, Barr...
October 31, 2005
Japan stock market week to Oct 24.(pharmaceutical index )
October 31, 2005
Bayer HealthCare announces new charitable giving campaign.(charitable ...
October 31, 2005
Repligen in uridine deal with Stanley Med Res Inst.(Stanley Medical Re...
October 31, 2005
InvestBio invests $14M in The Vaccine Company.(InvestBio Ventures)(Bri...
October 31, 2005
Tentative FDA OK for Three Rivers' Ribasphere.(Three Rivers Pharmaceut...
October 31, 2005
Merck KGaA sees 3rd-qtr EPS leap 56%.
October 31, 2005
Serono 3rd-qtr sales rise but profits dip.(Serono AG)(Brief Article)
October 31, 2005
Roche's CellCept ups transplantee lifespan.
October 31, 2005
Chiron moves on with flu cell culture vaccine.(influenza vaccine)(Brie...
October 31, 2005
Aridigm/United Thera enter PAH accord.(Aradigm Corp., United Therapeut...
October 31, 2005
Excellent Ph III results with Herceptin.(Genentech Inc.)(Brief Article...
October 31, 2005
EU wants more trials on CV's ranolazine.(CV Therapeutics Inc.)(Brief A...
October 31, 2005
GSK drops Ono's HIV drug aplaviroc.(Bristol-Myers Squibb Co., Ono Phar...
October 31, 2005
Editor's view on Pfizer results; IMS market slowdown warning.(Letter t...
October 31, 2005
Depomed completes gabapentin Ph II enrollment.(gabapentin GR )(Brief A...
October 31, 2005
Ceragenix to enter CRADA for its CSA.(Centers for Disease Control and ...
October 31, 2005
Roche Canada suspends sales of Tamiflu.(Roche Holding Ltd.)(Brief Arti...
October 31, 2005
Uncertainties over UK generics law changes.(UK Medicines (Marketing Au...
October 31, 2005
EU states to stock their own antivirals.(European Union Health Ministe...
October 31, 2005
French govt health cost moves under attack.(health care costs)(Brief A...
October 31, 2005
Six blockbusters to go off-patent in 2006, world Rx market will grow 6...
October 31, 2005
"No price rises" in 1st yr of India's new Rx policy.(drug pr...
October 31, 2005
TRIPS "utterly inadequate" to solve pharma price crisis, WTO...
October 31, 2005
Approvable letter for Cephalon's Sparlon.(treatment of attention-defic...
October 31, 2005
Marshall Edwards' PXD sees good patient data.(phenoxodiol)(Brief Artic...
October 31, 2005
GSK and Aeras join forces on TB vacc.(GlaxoSmithKline PLC, Aeras Globa...
October 31, 2005
S-P's Noxafil fares better than Diflucan in GVHD.
October 31, 2005
Actelion announces a 40% increase in net revenues and a strong drug pi...
October 31, 2005
NsGene receives fee from Biogen Idec for Neublastin progress.(NsGene A...
October 31, 2005
Domantis and Argenta announce positive inhaled Ab study data.(Argenta ...
October 31, 2005
Cambridge Biostability develops improved vaccine storage tech.(biotech...
October 31, 2005
CAT and Abbott agree on Humira royalties.(Cambridge Antibody Technolog...
October 31, 2005
Chiron's 3rd-qtr revenue falls short of analysts forecasts.(biotechnol...
October 31, 2005
AstraZeneca's 3rd-qtr pretax profits leap 23%.
October 31, 2005
Idenix prices $150M offering.(Idenix Pharmaceuticals Inc.)(Brief Artic...
October 31, 2005
Avastin will be primary driver in ovarian cancer drug market, says Dec...
October 31, 2005
FDA to review Insmed's response to approvable letter for iPlex.(mecase...
October 31, 2005
Stock Commentary - New York week to Oct 24.(pharmaceutical industry)(B...
October 31, 2005
Merck KGaA elects Wilhelm Simson chairman of its supervisory board.
October 31, 2005
Jean-Yves Wessely to head Sanofi-Aventis' Winthrop unit.(Sterling Drug...
October 31, 2005
Germany's Jerini sets IPO price.
October 31, 2005
US FDA accepts Discovery Labs' NDA on Surfaxin as complete.(Discovery ...
October 31, 2005
Discovery Partners sign accord with Ono.(Discovery Partners Internatio...
October 31, 2005
BioWa and OncoTherapy enter R&D deal on anticancer MAbs.(monoclonal an...
October 31, 2005
Abbott Labs withdraws ADHD drug pemoline.
October 31, 2005
TopoTarget starts dosing in PhII Baceca trial.(treatment for skin canc...
October 31, 2005
sBLA for Genetech/Biogen Idec's Rituxan assigned priority review.(supp...
October 31, 2005
Boehringer Ingelheim's Aptivus gets expanded indication in EU.(marketi...
October 31, 2005
Pharming names Wim Burgemeestre as head of finance and admin.(Pharming...
October 31, 2005
Antigenics begins Ph I Aroplatin study.(treatment of advanced solid ma...
October 31, 2005
Medical University of South Carolina to conduct Prometa alcohol study....
October 31, 2005
European Parliament's pediatric testing legislation reviewed by Linda ...
October 31, 2005
Pharma needs to improve its risk-management, says KPMG.
October 31, 2005
Teva targets 8% of Spain's generics by 2008.(Teva Pharmaceutical Indus...
October 31, 2005
Wyeth earnings hit by restructuring charges.(Brief Article)
October 31, 2005
Schering AG beats forecasts, raises goals.(Brief Article)
October 31, 2005
MedImmune completes buy of Cellective.(Cellective Therapeutics)(Brief ...
October 31, 2005
Jilin Xiuzheng sales rise 80%.(Jilin Xiuzheng Pharma Group)(Brief Arti...
October 31, 2005
Lost Vioxx sales drug on Merck & Co's 3rd-qtr results, but profits sti...
October 31, 2005
BioWa to develop anti-FGF8 MAb outside Asia.(anti-fibroblast growth fa...
October 31, 2005
Corcept and Eli Lilly to develop GR II antagonist.(Corcept Therapeutic...
October 31, 2005
Syntonix to develop delivery of BI's peptides.(Syntonix Pharmaceutical...
October 31, 2005
MabCampath effective in B-Cell CLL, says trial.(Leukemia drugs )(Brief...
October 31, 2005
MedImmune's 3rd-qtr loss stays same.(Brief Article)
October 31, 2005
Endo's 2005 3rd qtr EPS rises 61%, sales up 60.9 %.(Endo Pharmaceutica...
October 31, 2005
Good safety data on Pharming's lactoferrin.(Pharming Group N.V.'s repo...
October 31, 2005
Wyeth to take Oxford BioMedica's candidate into development.(Brief Art...
October 31, 2005
Cozart gets UK patent for MDMD test.(Cozart Bioscience)(Brief Article)
October 31, 2005
Industry assesses first experiences with parallel EMEA/FDA scientific ...
October 31, 2005
2004's $20B in untapped savings from generics USA-wide: PBM report.
October 31, 2005
Wyeth calls for FDA investigation of "custom Hormone cocktails&qu...
October 31, 2005
|
1